Pharmacokinetics of thiamylal enantiomers in humans

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 3, 1997, Pages 128-132

  Sueyasu, M ^a   Ikeda, T ^a   Taniyama, T ^a   Futugami, K ^a   Kataoka, Y ^a   Oishi, R ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Enantiomer; Pharmacokinetics; Protein binding; Thiamylal

Indexed keywords

THIAMYLAL; THIOBARBITURIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; ENANTIOMER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; RACEMIC MIXTURE; SCHOOL CHILD;

ADULT; AGED; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROTEIN BINDING; SEIZURES; STEREOISOMERISM; THIAMYLAL;

EID: 0030939938     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Burch PG, Stanski R 1982 Decreased protein binding and thiopental kinetics. Clin Pharmacol Ther 32: 212-217
2. Burch PG, Stanski DR 1983 The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology 58: 146-152
3. Carroll FI, Smith D, Mark LC, Brand L, Perel JM 1977 Determination of optically active thiopental, thiamylal, and their metabolites in human urine. Drug Metab Dispos 5: 343-354
4. Chandler MH, Scott SR, Blounin RA 1988 Age-associated stereoselective alterations in hexobarbital metabolism. Clin Pharmacol Ther 43: 436-441
5. Cook CE, Seltzman TB, Tallent CR, Lorenzo B, Drayer DE 1981 Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits. J Pharmacol Exp Ther 241: 779-785
6. Hashimoto M, Kajiwara H, Kadoya C 1987 Barbiturate therapy in 16 cases with intracranial lesion with special reference to the indication and limitation. Sangyo Ika Daigaku Zasshi 9: 149-156
7. Hooper WD, Qing MS 1990 The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans. Clin Pharmacol Ther 48: 633-640
8. Huang JD 1990 Comparative drug exsorption in the perfused rat intestine. J Pharm Pharmacol 42: 167-170
9. Levy RH, Moreland TA 1984 Rationale for monitoring free drug levels. Clin Pharmacokinet 9 (Suppl 1): 1-9
10. MacKichan JJ 1984 Pharmacokinetic consequences of drug displacement from blood and tissue proteins. Clin Pharmacokinet 9 (Suppl 1): 32-41
11. Mark LC, Brand L, Kamvyssi S, Britton RC, Perel JM, Landrau MA 1965 Thiopental metabolism by human liver in vivo and in vitro. Nature 206: 1117-1119
12. Morikawa N, Higuchi K, Tsukamoto T 1990 Pharmacokinetics of thiamylal following bolus injection and continuous administration. Yakuzaigaku 50: 246-255
13. Rowland M 1984 Protein binding and drug clearance. Clin Pharmacokinet 9 (Suppl 1): 10-17
14. Russo H, Audran M, Bressolle F, Bres J, Maillols H 1993 Displacement of thiopental from human serum albumin by associated drugs. J Pharm Sci 82: 493-497
15. Sams RA, Muir WW, Detra RL, Robinson EP 1985 Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs. Am J Vet Res 46: 1677-1683
16. Sueyasu M, Ikeda T, Otsubo K, Taniyama T, Aoyama T, Oishi R 1995 Enantioselective determination of thiamylal in human serum by high-performance liquid chromatography. J Chromatogr Biomed Appl 665: 133-137
17. Ujike Y, Namiki A, Fujisawa S 1985 Thiamylal coma therapy of refractory symptomatic convulsive status epileptics. Masui 34: 1384-1390
18. Watanabe H, Ohdo S, Ishikawa M, Ogawa N 1992 Effects of social isolation on pentobarbital activity in mice: Relationship to racemate levels and enantiomer levels in brain. J Pharmacol Exp Ther 263: 1036-1045
19. Wertz EM, Benson GJ, Thurmon JC, Tranquilli WJ, Davis LE, Koritz GD 1988 Pharmacokinetics of thiamylal in cats. Am J Vet Res 49: 1079-1083
20. Wyngaarden JB, Woods LA, Ridley R, Seevers MH 1949 Anesthetic properties of sodium 5-allyl-5-(1-methylbutyl)-2-thiobarbiturate (Surital) and certain other thiobarbilurates in dogs. J Pharmacol Exp Ther 95: 322-327